Company / Return on Equity (ROE)
Cardlytics, Inc. Return on Equity (ROE) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-270.5%
FY2024
5-year range
-270.5% / -33.0%
FY2020-FY2024
Trend
-170.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cardlytics, Inc. reports negative total equity of -270.5% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-270.5% in FY2024 with a 3-year CAGR of -237.5%.
Declined from -35.3% to -270.5% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -237.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Cardlytics, Inc.'s return on equity (roe) has declined for 3 consecutive years.
- In FY2024, return on equity (roe) decreased 170.6% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -270.5% | -170.6% |
| FY2023 | -99.9% | -183.4% |
| FY2022 | -35.3% | -6.9% |
| FY2021 | -33.0% | +67.7% |
| FY2020 | -102.0% | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026